Nuvation Bio Inc
(NUVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,726 | -104,199 | -83,354 | -56,151 | -21,293 |
| Depreciation Amortization | 56 | 199 | 150 | 94 | 46 |
| Accounts payable and accrued liabilities | 806 | -1,786 | -930 | 8,803 | 5,748 |
| Other Working Capital | -299 | -3,447 | -3,631 | 768 | -2,921 |
| Other Operating Activity | 1,833 | 13,125 | 7,826 | -5,361 | -6,509 |
| Operating Cash Flow | $-19,330 | $-96,108 | $-79,939 | $-51,847 | $-24,929 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -51,984 | 63,814 | 85,584 | 21,285 | -5,544 |
| PPE Investments | -12 | -357 | -298 | -202 | -7 |
| Investing Cash Flow | $-51,996 | $63,457 | $85,286 | $21,083 | $-5,551 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 298 | 1,327 | 920 | 662 | 314 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 3,950 |
| Financing Cash Flow | $298 | $1,327 | $920 | $662 | $4,264 |
| Beginning Cash Position | 101,099 | 132,423 | 132,423 | 132,423 | 132,423 |
| End Cash Position | 30,071 | 101,099 | 138,690 | 102,321 | 106,207 |
| Net Cash Flow | $-71,028 | $-31,324 | $6,267 | $-30,102 | $-26,216 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,330 | -96,108 | -79,939 | -51,847 | -24,929 |
| Capital Expenditure | -12 | -370 | -305 | -202 | -7 |
| Free Cash Flow | -19,342 | -96,478 | -80,244 | -52,049 | -24,936 |